search
Back to results

Survival TRaining for ENhancing Total Health (STRENGTH)

Primary Purpose

Breast Cancer, Depression, Weight Changes

Status
Completed
Phase
Phase 2
Locations
United States
Study Type
Interventional
Intervention
Calcium-Rich Diet
Arm 2: Exercise + Calcium-Rich Diet
Exercise + Fruit & Vegetable, Low Fat + Calcium Diet
Sponsored by
Duke University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional other trial for Breast Cancer focused on measuring weight changes, depression, stage I breast cancer, stage II breast cancer, stage IIIA breast cancer

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)FemaleDoes not accept healthy volunteers

DISEASE CHARACTERISTICS: Histologically confirmed breast cancer Stage I, II, or IIIA Scheduled to receive adjuvant chemotherapy OR received 1 prior course of chemotherapy Hormone receptor status: Not specified PATIENT CHARACTERISTICS: Age 18 and over Sex Female Menopausal Status Premenopausal, defined as at least 1 of the following: Less than 4 months since last menstrual period at diagnosis Follicle-stimulating hormone level in the premenopausal range Performance status Not specified Life expectancy Not specified Hematopoietic Not specified Hepatic Not specified Renal No calcium-based kidney stones Cardiovascular No angina within the past 6 months No myocardial infarction within the past 6 months No abnormal MUGA and/or stress test Other Not pregnant or nursing Access to a telephone Able to read and speak English No other prior or concurrent malignancy except curatively treated carcinoma in situ of the cervix or nonmelanoma skin cancer No history of hyperthyroidism or hypothyroidism No paralysis No osteoarthritis with uncontrolled joint pain that would preclude exercise No diverticulitis No serious medical or psychiatric illness that would preclude giving informed consent or completing study therapy or quality of life questionnaires No medical condition that would interfere with body composition assessment No medical condition for which unsupervised exercise is contraindicated No medical condition for which a high vegetable and fruit diet or a calcium-rich diet is contraindicated PRIOR CONCURRENT THERAPY: Biologic therapy Not specified Chemotherapy See Disease Characteristics Endocrine therapy Not specified Radiotherapy Not specified Surgery No prior bilateral oophorectomy No prior amputation No concurrent transverse rectus abdominis myocutaneous surgery No concurrent surgery Other No concurrent blood-thinners (e.g., coumadin or warfarin)

Sites / Locations

  • Duke Comprehensive Cancer Center
  • Southeastern Medical Oncology Center
  • Comprehensive Cancer Center at Wake Forest University
  • Cancer Centers of the Carolinas - Eastside

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Active Comparator

Active Comparator

Active Comparator

Arm Label

Arm 1: calcium diet

Arm 2: Exercise + Calcium-Rich Diet

Exercise + Fruit & Vegetable, Low Fat + Calcium Diet

Arm Description

Calcium-Rich Diet (dietary counseling + materials promoting an intake of 1,200 - 2,500 mg/day).

Exercise + Calcium Rich Diet (dietary counseling + materials promoting strength training and aerobic activity + a calcium intake of 1,200 - 2,500 mg/day).

Dietary counseling + materials promoting strength training and aerobic activity + a diet that has < 20% of energy coming from fat and intakes of fruits and vegetables of > 5 servings/day + a calcium intake of 1,200 - 2,500 mg/day. 6 month intervention.

Outcomes

Primary Outcome Measures

Distance Medicine Based Diet Exercise Program Within the Cooperative Group Setting
Assess estimates of effect sizes and to ascertain potential feasibility of implementing a distance-medicine based diet-exercise program within the cooperative group setting.

Secondary Outcome Measures

Full Information

First Posted
September 10, 2003
Last Updated
December 15, 2017
Sponsor
Duke University
Collaborators
National Cancer Institute (NCI)
search

1. Study Identification

Unique Protocol Identification Number
NCT00068458
Brief Title
Survival TRaining for ENhancing Total Health (STRENGTH)
Official Title
A Phase II Randomized Study to Assess the Feasibility of Distance Medicine Based Exercise and Dietary Approaches to Prevent Body Composition Change Occurring During Adjuvant Chemotherapy for Early Stage Breast Cancer
Study Type
Interventional

2. Study Status

Record Verification Date
April 2013
Overall Recruitment Status
Completed
Study Start Date
September 2003 (undefined)
Primary Completion Date
January 2004 (Actual)
Study Completion Date
January 2005 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Duke University
Collaborators
National Cancer Institute (NCI)

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
RATIONALE: A home-based exercise and/or diet program may improve the quality of life of breast cancer patients by preventing an increase in body fat and weight and a loss of lean body tissue. PURPOSE: This randomized phase II trial is studying the effectiveness of three home-based diet and/or exercise programs in preventing weight gain and loss of muscle tissue in women who are receiving chemotherapy for stage I, stage II, or stage IIIA breast cancer.
Detailed Description
OBJECTIVES: Compare the efficacy of exercise alone or combined with a modified diet as home-based interventions to prevent increases in body fat during adjuvant chemotherapy in women with stage I, II, or IIIA breast cancer. Compare the efficacy of these regimens, in terms of reducing gains in adipose tissue, reducing losses in absolute amounts of lean body tissue, reducing gains in weight, influencing levels of biomarkers associated with the risk of breast cancer and/or other comorbid conditions, improving self-efficacy for exercise behaviors, reducing depression, and improving quality of life in these patients. Compare the adherence rates to these regimens in these patients. Determine the associations between study condition and adherence and change in endpoints in patients treated with these regimens. Determine the feasibility of conducting home-based exercise and diet studies using the infrastructure of the cooperative group. OUTLINE: This is a pilot, randomized, multicenter study. Patients are stratified according to body mass index (no more than 25 kg/m^2 vs more than 25 kg/m^2), race (white vs non-white), and prior exercise history (vigorous exercise of at least 30 minutes, 3 times a week prior to diagnosis) (yes vs no). Patients are randomized to 1 of 3 treatment arms. Arm I (calcium-rich diet): Patients receive materials and counseling to promote a diet that contains ample amounts of calcium (1,200-2,500 mg/day). Arm II (calcium-rich diet and exercise): Patients receive materials and counseling as in arm I and instruction and materials to promote strength training and endurance exercises. Arm III (calcium-rich, high fruit and vegetable, low-fat diet and exercise): Patients receive materials and counseling as in arm II and materials and counseling to consume at least 5 servings of vegetables and fruit per day and limit fat intake to less than 20% of total calories. In all arms, patients continue regimens for 6 months. Measurements of body composition, weight, waist circumference, serum levels of insulin, insulin-like growth factor, sex hormone-binding globulin, and total cholesterol are obtained at baseline and 6 months. Quality of life, depression, diet composition, and physical activity are assessed at baseline and at 3 and 6 months. Patients are followed at 1 month. PROJECTED ACCRUAL: A total of 90 patients (30 per treatment arm) will be accrued for this study within 16 months.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Breast Cancer, Depression, Weight Changes
Keywords
weight changes, depression, stage I breast cancer, stage II breast cancer, stage IIIA breast cancer

7. Study Design

Primary Purpose
Other
Study Phase
Phase 2
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
39 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Arm 1: calcium diet
Arm Type
Active Comparator
Arm Description
Calcium-Rich Diet (dietary counseling + materials promoting an intake of 1,200 - 2,500 mg/day).
Arm Title
Arm 2: Exercise + Calcium-Rich Diet
Arm Type
Active Comparator
Arm Description
Exercise + Calcium Rich Diet (dietary counseling + materials promoting strength training and aerobic activity + a calcium intake of 1,200 - 2,500 mg/day).
Arm Title
Exercise + Fruit & Vegetable, Low Fat + Calcium Diet
Arm Type
Active Comparator
Arm Description
Dietary counseling + materials promoting strength training and aerobic activity + a diet that has < 20% of energy coming from fat and intakes of fruits and vegetables of > 5 servings/day + a calcium intake of 1,200 - 2,500 mg/day. 6 month intervention.
Intervention Type
Dietary Supplement
Intervention Name(s)
Calcium-Rich Diet
Other Intervention Name(s)
Calcium
Intervention Description
1,200 - 2,500 mg/day. 6 month intervention
Intervention Type
Other
Intervention Name(s)
Arm 2: Exercise + Calcium-Rich Diet
Other Intervention Name(s)
Calcium
Intervention Description
Dietary counseling + material promoting strength training an aerobic activity + a calcium intake of 1,200 - 2,500 mg/day. 6 month intervention.
Intervention Type
Other
Intervention Name(s)
Exercise + Fruit & Vegetable, Low Fat + Calcium Diet
Other Intervention Name(s)
Calcium
Intervention Description
1,200 - 2,500 Calcium intake per day. 6 month intervention period.
Primary Outcome Measure Information:
Title
Distance Medicine Based Diet Exercise Program Within the Cooperative Group Setting
Description
Assess estimates of effect sizes and to ascertain potential feasibility of implementing a distance-medicine based diet-exercise program within the cooperative group setting.
Time Frame
6 months

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
DISEASE CHARACTERISTICS: Histologically confirmed breast cancer Stage I, II, or IIIA Scheduled to receive adjuvant chemotherapy OR received 1 prior course of chemotherapy Hormone receptor status: Not specified PATIENT CHARACTERISTICS: Age 18 and over Sex Female Menopausal Status Premenopausal, defined as at least 1 of the following: Less than 4 months since last menstrual period at diagnosis Follicle-stimulating hormone level in the premenopausal range Performance status Not specified Life expectancy Not specified Hematopoietic Not specified Hepatic Not specified Renal No calcium-based kidney stones Cardiovascular No angina within the past 6 months No myocardial infarction within the past 6 months No abnormal MUGA and/or stress test Other Not pregnant or nursing Access to a telephone Able to read and speak English No other prior or concurrent malignancy except curatively treated carcinoma in situ of the cervix or nonmelanoma skin cancer No history of hyperthyroidism or hypothyroidism No paralysis No osteoarthritis with uncontrolled joint pain that would preclude exercise No diverticulitis No serious medical or psychiatric illness that would preclude giving informed consent or completing study therapy or quality of life questionnaires No medical condition that would interfere with body composition assessment No medical condition for which unsupervised exercise is contraindicated No medical condition for which a high vegetable and fruit diet or a calcium-rich diet is contraindicated PRIOR CONCURRENT THERAPY: Biologic therapy Not specified Chemotherapy See Disease Characteristics Endocrine therapy Not specified Radiotherapy Not specified Surgery No prior bilateral oophorectomy No prior amputation No concurrent transverse rectus abdominis myocutaneous surgery No concurrent surgery Other No concurrent blood-thinners (e.g., coumadin or warfarin)
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Edward G. Shaw, MD
Organizational Affiliation
Wake Forest University Health Sciences
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Wendy Demark-Wahnefried, PhD
Organizational Affiliation
Duke Cancer Institute
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Roger T. Anderson, PhD
Organizational Affiliation
Wake Forest University Health Sciences
Official's Role
Study Chair
Facility Information:
Facility Name
Duke Comprehensive Cancer Center
City
Durham
State/Province
North Carolina
ZIP/Postal Code
27710
Country
United States
Facility Name
Southeastern Medical Oncology Center
City
Goldsboro
State/Province
North Carolina
ZIP/Postal Code
27534
Country
United States
Facility Name
Comprehensive Cancer Center at Wake Forest University
City
Winston-Salem
State/Province
North Carolina
ZIP/Postal Code
27157-1030
Country
United States
Facility Name
Cancer Centers of the Carolinas - Eastside
City
Greenville
State/Province
South Carolina
ZIP/Postal Code
29615
Country
United States

12. IPD Sharing Statement

Citations:
PubMed Identifier
18501061
Citation
Demark-Wahnefried W, Case LD, Blackwell K, Marcom PK, Kraus W, Aziz N, Snyder DC, Giguere JK, Shaw E. Results of a diet/exercise feasibility trial to prevent adverse body composition change in breast cancer patients on adjuvant chemotherapy. Clin Breast Cancer. 2008 Feb;8(1):70-9. doi: 10.3816/CBC.2008.n.005.
Results Reference
result

Learn more about this trial

Survival TRaining for ENhancing Total Health (STRENGTH)

We'll reach out to this number within 24 hrs